Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza vs Prednisolone for Post-Surgical Inflammation in Retinal Detachment
NCT04464629Phase 4Terminated
- Sponsor
- Midwest Eye Institute
- Start
- Jul 2020
- Primary completion
- Jan 2023
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in ocular inflammation, post-operative ocular pain, sponsored by Midwest Eye Institute. Started Jul 2020; status: terminated.
02
Drugs
ozurdex
03
Conditions
ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT04464629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04464629.